Clinical Trial Update: Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy [NA]

View source ↗

Summary

The Netherlands Cancer Institute reports ongoing recruitment for a trial validating ICG-99mTc-nanoscan as a hybrid tracer for sentinel lymph node biopsy in peni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Oral Cancer
• Penile Cancer

Drugs mentioned

• ICG-99mTc-nanoscan

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Penile Cancer, Melanoma | NA | Status: RECRUITING